Varied biologic functions of C-reactive protein - Lessons learned from transgenic mice

被引:65
作者
Szalai, AJ [1 ]
McCrory, MA [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
关键词
acute-phase proteins; innate immunity; regulation; host defense; apoptosis; experimental allergic encephalomyelitis; systemic lupus erythematoses; arteriosclerosis;
D O I
10.1385/IR:26:1-3:279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our investigations of human Greactive protein (CRP) and CRP transgenic mice have produced novel data that firmly establish this protein as an important host defense molecule. For example, we have learned that depending on the disease model, the beneficial effect of CRP can be direct, depend on the protein's ability to engage complement and Fcgamma receptors, or rely on its ability to bridge innate and adaptive immunity. In addition, the degree of protection correlates with acute phase expression, but more important, also with the amount of CRP expressed constitutively. Furthermore, differences in baseline levels of CRP among healthy individuals and among patients can be attributed to a CRP gene polymorphism. In this article, we discuss these and other observations we have made during the last 5 yr and summarize our ongoing studies and future plans related to CRP biology.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 31 条
[1]   The occurrence during acute infections of a protein not normally present in the blood I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus [J].
Abernethy, TJ ;
Avery, OT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1941, 73 (02) :173-182
[2]   THE STRINGENCY AND MAGNITUDE OF ANDROGEN-SPECIFIC GENE ACTIVATION ARE COMBINATORIAL FUNCTIONS OF RECEPTOR AND NONRECEPTOR BINDING-SITE SEQUENCES [J].
ADLER, AJ ;
SCHELLER, A ;
ROBINS, DM .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) :6326-6335
[3]  
AGRAWAL A, 1994, J IMMUNOL, V152, P5404
[4]  
ANDERSON JK, 1978, FED PROC, V37, P1495
[5]   The major receptor for C-reactive protein on leukocytes is Fcγ receptor II [J].
Bharadwaj, D ;
Stein, MP ;
Volzer, M ;
Mold, C ;
Du Clos, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (04) :585-590
[6]  
Burlingame RW, 1996, J IMMUNOL, V156, P4783
[7]   INDUCIBLE AND TISSUE-SPECIFIC EXPRESSION OF HUMAN C-REACTIVE PROTEIN IN TRANSGENIC MICE [J].
CILIBERTO, G ;
ARCONE, R ;
WAGNER, EF ;
RUTHER, U .
EMBO JOURNAL, 1987, 6 (13) :4017-4022
[8]   DECREASED AUTOANTIBODY LEVELS AND ENHANCED SURVIVAL OF (NZB X NZW) F(1) MICE TREATED WITH C-REACTIVE PROTEIN [J].
DUCLOS, TW ;
ZLOCK, LT ;
HICKS, PS ;
MOLD, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (01) :22-27
[9]   C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity [J].
Gershov, D ;
Kim, S ;
Brot, N ;
Elkon, KB .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) :1353-1363
[10]  
LEI KJ, 1985, J BIOL CHEM, V260, P3377